Clinical trial
Autologous T Cell Immunotherapy for Chronic Lymphocytic Leukemia (CLL) Patients
NCT00058656 · Xcyte Therapies, Industry · Completed
Key facts
| NCT number | NCT00058656 |
|---|---|
| Title | Autologous T Cell Immunotherapy for Chronic Lymphocytic Leukemia (CLL) Patients |
| Official title | A Phase I/II Study of Xcellerated T Cells(tm) in Patients With Chronic Lymphocytic Leukemia (CLL) |
| Lead sponsor | Xcyte Therapies, Industry |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Chronic Lymphocytic Leukemia |
| Intervention type | Procedure |
| Interventions | Infusion of Activated & Expanded Autologous T Cells |
| Enrollment | 18 |
| Start date | Mar 1, 2003 |
| First posted | Apr 10, 2003 |
| Last update posted | Nov 22, 2006 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: